{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:42:43Z","timestamp":1786117363890,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH-P40-OD-010939"],"award-info":[{"award-number":["NIH-P40-OD-010939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymthe.2025.04.030","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:02:55Z","timestamp":1745535775000},"page":"3808-3821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Age-sensitive response of systemic AAV-mediated gene therapy in a newly characterized feline model of mucolipidosis II"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6785-7846","authenticated-orcid":false,"given":"Nettie K.","family":"Pyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Shyng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Odonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Miyadera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Srnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Pesayco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Diane","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Antoine","family":"Assenmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Flanagan-Steet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-3743","authenticated-orcid":false,"given":"Allison M.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.04.030_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112262","article-title":"Trafficking of lysosomal enzymes in normal and disease states","volume":"77","author":"Kornfeld","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.04.030_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejcb.2009.10.008","article-title":"Mannose phosphorylation in health and disease","volume":"89","author":"Kollmann","year":"2010","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.04.030_bib3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI110189","article-title":"Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity","volume":"67","author":"Reitman","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.04.030_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.cb.05.110189.002411","article-title":"The biogenesis of lysosomes","volume":"5","author":"Kornfeld","year":"1989","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.04.030_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmg.2009.067736","article-title":"Phenotype and genotype in mucolipidoses II and III alpha\/beta: a study of 61 probands","volume":"47","author":"Cathey","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymthe.2025.04.030_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12917-018-1728-1","article-title":"A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease)","volume":"14","author":"Wang","year":"2018","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.ymthe.2025.04.030_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jhered\/esg080","article-title":"Inheritance, biochemical abnormalities, and clinical features of feline mucolipidosis II: the first animal model of human I-cell disease","volume":"94","author":"Mazrier","year":"2003","journal-title":"J. Hered."},{"key":"10.1016\/j.ymthe.2025.04.030_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jbmr.2722","article-title":"Cathepsin-Mediated Alterations in TGFss-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting","volume":"31","author":"Flanagan-Steet","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymthe.2025.04.030_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109768","article-title":"Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III gamma","volume":"9","author":"Idol","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2025.04.030_bib10","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","article-title":"Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)","volume":"36","author":"Bosch","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.04.030_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2016.013","article-title":"Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease","volume":"27","author":"Karumuthil-Melethil","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mt.2014.240","article-title":"Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates","volume":"23","author":"Walia","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/hum.2012.029","article-title":"Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer","volume":"23","author":"Ruzo","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/humc.2015.132","article-title":"A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB","volume":"26","author":"Meadows","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.04.030_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2015.189","article-title":"Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII","volume":"24","author":"Gurda","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib16","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","article-title":"Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan","volume":"24","author":"Weismann","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.04.030_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/humc.2013.208","article-title":"Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates","volume":"25","author":"Murrey","year":"2014","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.04.030_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/brain\/awab309","article-title":"Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis","volume":"145","author":"Gross","year":"2022","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.04.030_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-0004.1995.tb03958.x","article-title":"Inter- and intrafamilial variability in mucolipidosis II (I-cell disease)","volume":"47","author":"Beck","year":"1995","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymthe.2025.04.030_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00707197","article-title":"Craniosynostosis and hydrocephalus in I-cell disease (mucolipidosis II)","volume":"3","author":"Yamada","year":"1987","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.ymthe.2025.04.030_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/BF02762185","article-title":"I-cell disease (Mucolipidosis II)","volume":"67","author":"Kabra","year":"2000","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.ymthe.2025.04.030_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00381-002-0627-7","article-title":"A case of I-cell disease (mucolipidosis II) presenting with craniosynostosis","volume":"18","author":"Aynaci","year":"2002","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.ymthe.2025.04.030_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5144\/0256-4947.2013.382","article-title":"Mucolipidosis II: first report from Saudi Arabia","volume":"33","author":"Alfadhel","year":"2013","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.ymthe.2025.04.030_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/1817-1745.131480","article-title":"Craniosynostosis in a child with I-cell disease: The need for genetic analysis before contemplating surgery in craniosynostosis","volume":"9","author":"Chittem","year":"2014","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.ymthe.2025.04.030_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/humc.2015.002","article-title":"A review of gene therapy in canine and feline models of lysosomal storage disorders","volume":"26","author":"Bradbury","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.04.030_bib26","first-page":"417","article-title":"Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies","volume":"90","author":"Gurda","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.04.030_bib27","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1093\/hmg\/ddz127","article-title":"Large animal models contribute to the development of therapies for central and peripheral nervous system dysfunction in patients with lysosomal storage diseases","volume":"28","author":"Gurda","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.04.030_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/gt.2014.108","article-title":"Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease","volume":"22","author":"McCurdy","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.10.047","article-title":"AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease","volume":"340","author":"Bradbury","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2025.04.030_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415569908","article-title":"AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system","volume":"7","author":"Rockwell","year":"2015","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ymthe.2025.04.030_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41434-020-00190-1","article-title":"Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease","volume":"28","author":"McCurdy","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib32","doi-asserted-by":"crossref","first-page":"14894","DOI":"10.1073\/pnas.1413645111","article-title":"Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I","volume":"111","author":"Hinderer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.030_bib33","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/mt.2014.135","article-title":"Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I","volume":"22","author":"Hinderer","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/awaa161","article-title":"Global CNS correction in a large brain model of human alpha-mannosidosis by intravascular gene therapy","volume":"143","author":"Yoon","year":"2020","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.04.030_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2015.168","article-title":"Clinical Improvement of Alpha-mannosidosis Cat Following a Single Cisterna Magna Infusion of AAV1","volume":"24","author":"Yoon","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/mt.2010.257","article-title":"Long-term amelioration of feline Mucopolysaccharidosis VI after AAV-mediated liver gene transfer","volume":"19","author":"Cotugno","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/hum.2012.179","article-title":"Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8","volume":"24","author":"Ferla","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib38","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200052","article-title":"Liver-Directed Adeno-Associated Virus\u2013Mediated Gene Therapy for Mucopolysaccharidosis Type VI","volume":"1","author":"Brunetti-Pierri","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.ymthe.2025.04.030_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymthe.2023.11.014","article-title":"Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy","volume":"32","author":"Bradbury","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib40","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"Febs j"},{"key":"10.1016\/j.ymthe.2025.04.030_bib41","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0022034515604621","article-title":"RANTES and SDF-1 Are Keys in Cell-based Therapy of TMJ Osteoarthritis","volume":"94","author":"Lu","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ymthe.2025.04.030_bib42","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4103\/1673-5374.332148","article-title":"Ocular therapies for neuronal ceroid lipofuscinoses: more than meets the eye","volume":"17","author":"Murray","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymthe.2025.04.030_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.04.030_bib44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2025.04.030_bib45","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2021.1272","article-title":"Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy","volume":"78","author":"Mendell","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2025.04.030_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/NEN.0b013e318286587f","article-title":"Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C","volume":"72","author":"Bagel","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.04.030_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.030_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.omtm.2017.03.006","article-title":"Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy","volume":"5","author":"Liu","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:44:20Z","timestamp":1786023860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1525001625003090"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.030","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-sensitive response of systemic AAV-mediated gene therapy in a newly characterized feline model of mucolipidosis II","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}